Development asset linked to Eledon Pharmaceuticals in public FDA and regional records.
pharma · Type 1 Diabetes Mellitus · Prophylaxis of Renal Allograft Rejection · ELDN
Eledon Pharmaceuticals
Eledon Pharmaceuticals drug portfolio — 11 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Irvine, USA HQ
2020 Founded
42 Employees
Public company Type
ELDN · NYSE Ticker
Company details
- Status
- Public
- HQ
- Irvine, USA
- Founded
- 2020
- Employees
- 42
- Programs
- 9
- Drugs
- 11
- Patents
- 0
Eledon Pharmaceuticals pipeline
Portfolio lens on 11 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Eledon Pharmaceuticals drug portfolio — 11 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Eledon Pharmaceuticals in public FDA and regional records.
-
US regulatory status: approved. Molecular target: DNA.
- Target
- DNA
- Mechanism
- DNA inhibitor
-
Development asset linked to Eledon Pharmaceuticals in public FDA and regional records.
-
Development asset linked to Eledon Pharmaceuticals in public FDA and regional records.
-
Development asset linked to Eledon Pharmaceuticals in public FDA and regional records.
-
rituximab
Antineoplastic and immunomodulating agents (L01)US regulatory status: approved. Molecular target: B-lymphocyte antigen CD20.
- Target
- B-lymphocyte antigen CD20
- Mechanism
- B-lymphocyte antigen CD20 binding agent
-
Development asset linked to Eledon Pharmaceuticals in public FDA and regional records.
-
tacrolimus
Dermatologicals (D11)US regulatory status: approved. Molecular target: Peptidyl-prolyl cis-trans isomerase FKBP1A.
- Target
- Peptidyl-prolyl cis-trans isomerase FKBP1A
- Mechanism
- FK506-binding protein 1A inhibitor
-
Development asset linked to Eledon Pharmaceuticals in public FDA and regional records.
-
Development asset linked to Eledon Pharmaceuticals in public FDA and regional records.